The Lightning Round is extended in this CNBC.com exclusive feature.   Read More

I'm at the Needham & Company biotech conference in New York City. Whenever possible I like to attend events like this. It's a good place to get story ideas. The Needham meeting is competing this year with a similar one being put on by Goldman Sachs in Laguna Beach, CA.    Read More

The Dow tumbled badly Friday after oil shot up more than $11 to a new record. What's the "Word on the Street?"   Read More

Ahead of earnings Thursday, Pfizer announced plans to license a brain cancer drug from Avant Immunotherapeutics. Will Pfizer continue to buy its way to a promising drug pipeline?    Read More

New hope that the credit crisis is nearing an end sends stocks soaring as investors say good riddance to Q1. Also, the latest on Microsoft-Yahoo, Merck and Schering and more.   Read More

Shares of Merck and Schering-Plough are both under the weather Monday after a study said their Vytorin cholesterol drug isn't any better than a generic. Who wins and who loses?   Read More